Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. - sprookjes - yvandenbroek - TriplyDB

Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports.

Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports.

http://www.wikidata.org/entity/Q33623655

about

Erythropoietin or darbepoetin for patients with cancer Erythropoietin for patients with malignant disease Erythropoietin or Darbepoetin for patients with cancer Laboratory medicine quality indicators: a review of the literature.Serious hazards of transfusion (SHOT) initiative. Conclusion was not supported by data presented Analysis of blood transfusion predictors in patients undergoing elective oesophagectomy for cancer.Transfusion-related acute lung injury during plasma exchange: Suspecting the unsuspected.Acute lung injury after blood transfusion in mechanically ventilated patients.Enhanced detection of blood bank sample collection errors with a centralized patient database.Blood transfusion safety: A study of adverse reactions at the blood bank of a tertiary care center Possible transfusion-related acute lung injury (TRALI) in cardiac surgery patients Comparing near misses with actual mistransfusion events: a more accurate reflection of transfusion errors.'Noise' in microbiological screening assays.Leucocyte depletion of the blood supply - how will patients benefit?Predicting the Origins of Anti-Blood Group Antibody Specificity: A Case Study of the ABO A- and B-Antigens.Clinical impact of blood storage lesions.Impact of donor arm skin disinfection on the bacterial contamination rate of platelet concentrates.Microarray technology: the future of blood testing?National comparative audit of blood use in elective primary unilateral total hip replacement surgery in the UK.Paediatric transfusion.Medication errors: causes, prevention and reduction.Predictors and patterns of red blood cell transfusion use among newly diagnosed cancer patients with chemotherapy-associated anemia in Western Denmark (1998-2003)Nucleic acid amplification technology methods used in blood donor screening.Haematological care of the Jehovah's Witness patient.Nurses' knowledge of blood transfusion in medical training centers of Shahrekord University of Medical Science in 2004 Molecular nature of antigens implicated in immune neutropenias.Case report: The management of advanced oral cancer in a Jehovah's Witness using the Ultracision Harmonic Scalpel.Relationship between tort claims and patient incident reports in the Veterans Health Administration Hemostatic resuscitation in postpartum hemorrhage - a supplement to surgery.Managing the pre- and post-analytical phases of the total testing process.The burden of anaemia in patients with cancer.Audit on the efficient use of cross-matched blood in elective total hip and total knee replacement.Mechanical ventilation and the titer of antibodies as risk factors for the development of transfusion-related lung injury.The safety and efficacy of "bloodless" cardiac surgery.Uncross-matched red blood cells save lives.Comparison of efficacy and safety of topical versus intravenous tranexamic acid in total hip arthroplasty: A meta-analysis.Code development of the national hemovigilance system and expansion strategies for hospital blood banks.Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products.Epoetin beta in oncology: examining the current evidence.Transfusion-related acute lung injury (TRALI): current clinical and pathophysiologic considerations.

P2860

Q24202335-F6EFD878-C3C1-417C-9CEB-83BED849910A Q24245427-6A16B61D-C900-4104-B62D-4FF9F72C13A6 Q24245464-BFD64FBE-92F4-4703-88FB-1FDCF7083590 Q30228247-2D19A290-9345-407E-912E-5CE3C3DD9E64 Q30590733-912A83D3-1EA7-4AC7-8989-A2DD73F0A5AB Q33316560-89065C18-A7FC-45B9-8E34-C3DFD4AF8F94 Q33344069-3FD7C434-2B2A-479D-A81E-652DB8EDF6C9 Q33362738-4CE5E2B9-CE76-458B-903A-203DDA1B0F9E Q33451346-5DAA0AD0-1B54-439C-BB22-000FC300B160 Q33457829-DFDCC63A-DA87-4A30-BC5A-05DF9BAD38DB Q33564923-E4F9CAB0-7FB1-4EC0-91C9-28CD9E032564 Q33848517-999BD2FF-D55A-48E8-AFF0-ADF1FEC4577E Q33940527-B4617CEC-2CF1-4C28-88A8-5E2A5093C135 Q34022474-F9E67755-B11A-48AB-9340-43D6DC731C48 Q34076811-B970AB84-9C5E-481F-BDBA-9881E9475A1A Q34091215-D24793D1-BF10-4B7D-BE21-F6EE1C851B0B Q34153169-E352A778-F7F5-428B-943D-C845F1D2E1D5 Q34242406-B585FB67-7E6C-46F3-9504-D317A7CB199B Q34251710-563A594A-27E1-4759-A214-B1C51AF2EBAC Q34345113-0AE5AC57-419A-4796-8923-4326F90D1442 Q34527679-682333DE-548D-4901-B1D4-0FDFB9803619 Q34769270-14CE1A50-FD0C-4393-86B5-48D5C737AD5C Q34830170-79D00DC5-F4AB-41EF-BB23-908EE1747494 Q34929104-B4B93871-3FAB-47C6-AEA5-419F7AB81B0C Q34976821-1FDAA2BA-9B13-42C8-8B65-C3C56483666E Q34996176-7B95EF98-C0DB-49BA-9B88-4B8C6833EC64 Q35477732-AE43FB79-32F9-407C-A4A9-CDF194A83C64 Q35527463-15C5594F-21E7-4F46-BA1F-EE96877B7E85 Q35557436-00488DE0-470A-4E1B-B0CA-C2CEE96A4C53 Q35664864-D94AAB6A-6A6B-4B94-8884-AF8E801BFD5A Q35920738-ED11075F-BCAE-4607-B572-40730C39EC77 Q35969957-D30C5736-EA02-4512-AC17-40C1C869113F Q36023439-A157C3C4-65BF-4D6C-A5E3-B79300BC7268 Q36056765-C7035019-DB7A-4B7B-9C6A-7B0620BACDB8 Q36058735-108A8243-A936-42C0-AC98-EC0E31106295 Q36125303-029F2730-604F-4C18-9F14-65BB69370A77 Q36228003-4940F2AC-9AE6-455B-B87E-68DE64557457 Q36266542-5A6B9B33-19FB-49ED-81BF-BDF510F081CB Q36429666-E83751F0-25BA-49A4-B4FC-2E548EA8BCB2 Q36562864-7CE69A52-1254-442C-9412-5722AB7DDEB8

P2860

Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports.

http://www.wikidata.org/entity/Q33623655

description

1999 nî lūn-bûn

@nan

1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

name

Serious hazards of transfusion ...... the first two annual reports.

@ast

Serious hazards of transfusion ...... the first two annual reports.

@en

type

label

Serious hazards of transfusion ...... the first two annual reports.

@ast

Serious hazards of transfusion ...... the first two annual reports.

@en

prefLabel

Serious hazards of transfusion ...... the first two annual reports.

@ast

Serious hazards of transfusion ...... the first two annual reports.

@en

P1433

Q33623655-7B4B9678-6AB0-4ECB-933B-F4C373DF9417

P1476

Q33623655-2311D7A4-5744-452F-B21F-ACD4AD12FC8A

P2093

Q33623655-651F4EF0-5235-424C-9C62-A14241410080

Q33623655-7E086CF3-027F-4E49-BE80-749600201044

Q33623655-9F8B1005-CE5C-45BE-B633-5D5D05B10773

Q33623655-AA8D9067-FB0F-49EE-AE37-8154FF9F2296

Q33623655-C14E0E22-F72C-4CC3-829A-A3A7366840D7

Q33623655-C3FAD44C-7693-4D57-B9B7-901ABA066C3A

Q33623655-E1AB9DA2-59AD-4E71-87C3-1EA988DB96D8

Q33623655-EB1CEE04-83FB-4BC0-9CB7-B55B6F010F11

P2860

Q33623655-3A24071B-10B4-4F7F-908A-EF0AF5D6245D

Q33623655-4CDD8AB8-DDBC-42A8-A2E8-4E627FC044E8

Q33623655-51466C08-3FA3-4511-8DC6-2EA1336BC053

Q33623655-567E3ED9-56EA-41A2-8BF5-E18DB47FA173

Q33623655-75C3ACAE-25E1-4E82-A581-69956C69AAAE

Q33623655-79E30B97-A455-4C81-9B19-26D3A787AF01

Q33623655-95E71DE2-CF25-4BFE-8A0E-C789AE0544ED

Q33623655-B0F3AAE9-D8E0-4984-84BB-4B96C3382B1D

Q33623655-FC52E533-207B-4036-84F1-2701D13092EF

P304

Q33623655-7F15F1FA-AC04-4E7D-86D1-1944BD3075A6

P31

Q33623655-A5881026-FC2F-41B3-BE4C-1FE2200305BB

P356

Q33623655-8AA1CD0F-BA65-4B27-A8BF-589A3735806F

P407

Q33623655-B2A5D52D-3CA8-455B-9310-39B3E9236EA0

P433

Q33623655-E0F5EB92-1798-4ABE-B8DF-A991C8640A67

P478

Q33623655-DD40F3DB-F78E-43A9-B599-FD436EBC7E51

P577

Q33623655-26B3C398-DF3C-4F0A-975F-A5022DB3D9AB

P5875

Q33623655-BB232948-E2A6-4738-ACF0-4A463EFB766F

P698

Q33623655-375E117E-64B2-48FC-BB32-5554425021B8

P932

Q33623655-522D0BB7-8430-4598-B742-5B0050A4F4D5

P356

BMJ.319.7201.16

P1433

P1476

Serious hazards of transfusion ...... the first two annual reports.

@en

P2093

D B McClelland

http://www.w3.org/2001/XMLSchema#string

E M Love

http://www.w3.org/2001/XMLSchema#string

H Cohen

http://www.w3.org/2001/XMLSchema#string

J A Barbara

http://www.w3.org/2001/XMLSchema#string

K Soldan

http://www.w3.org/2001/XMLSchema#string

L M Williamson

http://www.w3.org/2001/XMLSchema#string

P Skacel

http://www.w3.org/2001/XMLSchema#string

S Lowe

http://www.w3.org/2001/XMLSchema#string

P2860

Adherence to a strict specimen-labeling policy decreases the incidence of erroneous blood grouping of blood bank specimens.

Cancer: science and society and the communication of risk.

Errors in blood transfusion in Britain: survey of hospital haematology departments

Reports of 355 transfusion-associated deaths: 1976 through 1985.

Bacterial contamination of cellular blood components.

Transfusion safety: realigning efforts with risks.

A SHOT in the arm for safer blood transfusion.

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.

Identification and classification of the causes of events in transfusion medicine.

P304

16-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.319.7201.16

http://www.w3.org/2001/XMLSchema#string

P407

P433

7201

http://www.w3.org/2001/XMLSchema#string

P478

319

http://www.w3.org/2001/XMLSchema#string

P577

1999-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12909672

http://www.w3.org/2001/XMLSchema#string

P698

10390452

http://www.w3.org/2001/XMLSchema#string

P932

28147

http://www.w3.org/2001/XMLSchema#string